We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca to Complete Buy of Cambridge Antibody
AstraZeneca to Complete Buy of Cambridge Antibody
May 15, 2006
AstraZeneca announced it will buy the remaining shares of UK-based Cambridge Antibody Technology Group (CAT) for just over the equivalent of $1.07 billion.